Literature DB >> 11673357

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.

V Fuster, L E Rydén, R W Asinger, D S Cannom, H J Crijns, R L Frye, J L Halperin, G N Kay, W W Klein, S Lévy, R L McNamara, E N Prystowsky, L S Wann, D G Wyse, R J Gibbons, E M Antman, J S Alpert, D P Faxon, V Fuster, G Gregoratos, L F Hiratzka, A K Jacobs, R O Russell, S C Smith, W W Klein, A Alonso-Garcia, C Blomström-Lundqvist, G de Backer, M Flather, J Hradec, A Oto, A Parkhomenko, S Silber, A Torbicki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11673357

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  146 in total

1.  Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program.

Authors:  J L M Hendriks; R Nieuwlaat; H J M Vrijhoef; R de Wit; H J G M Crijns; R G Tieleman
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

Review 2.  Classifications and practice guidelines in atrial fibrillation: a changing landscape.

Authors:  Sanjeev Saksena
Journal:  J Interv Card Electrophysiol       Date:  2003-02       Impact factor: 1.900

3.  The return of "negative" trials?

Authors:  Mario L de Lemos
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

Review 4.  Randomized trials of rate vs. rhythm control for atrial fibrillation.

Authors:  Mina K Chung
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

Review 5.  Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment.

Authors:  Vias Markides; Richard J Schilling
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

Review 6.  Role of oral anticoagulation in management of atrial fibrillation.

Authors:  Eugene Crystal; Stuart J Connolly
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

7.  [Recommendations of the European Stroke Initiative (EUSI) for treatment of ischemic stroke--update 2003. Part 2: prevention and rehabilitation].

Authors:  Sonja Külkens; Peter Arthur Ringleb; Werner Hacke
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

Review 8.  The role of echocardiography in atrial fibrillation and cardioversion.

Authors:  Richard W Troughton; Craig R Asher; Allan L Klein
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

Review 9.  Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation.

Authors:  Gerald V Naccarelli; John Hynes; Deborah L Wolbrette; Luna Bhatta; Mazhar Khan; Jerry Luck
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

10.  Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital.

Authors:  Z R Yousef; S C Tandy; V Tudor; F Jishi; R J Trent; D K Watson; R P W Cowell
Journal:  Heart       Date:  2004-11       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.